Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Rehabil Res Clin Transl ; 4(3): 100203, 2022 Sep.
Article in English | MEDLINE | ID: mdl-36123986

ABSTRACT

Objective: To assess the feasibility of a hand use and grasp sensor system in collecting and quantifying fine motor development longitudinally in an infant's home environment. Design: Cohort study. Researchers made home visits monthly to participating families to collect grasp data from infants using a hand use and grasp sensor. Setting: Data collection were conducted in each participant's home. Participants: A convenience sample of 14 typical developmental infants were enrolled from 3 months to 9 months of age. Two infants dropped out. A total of 62 testing sessions involving 12 infants were available for analysis (N=12). Interventions: At each session, the infant was seated in a standardized infant seat. Each instrumented toy was hung on the hand use and grasp sensor structure, presented for 6 minutes in 3 feedback modes: visual, auditory, and vibratory. Main Outcome Measures: Infant grasp frequency and duration, peak grasping force, average grasping force, force coefficient of variation, and proportion of bimanual grasps. Results: A total of 2832 recorded grasp events from 12 infants were analyzed. In linear mixed-effects model analysis, when interacting with each toy, infants' peak grasp force, average grasp force, and accumulated grasp time all increased significantly with age (all P<.001). Bimanual grasps also occupied an increasingly greater percentage of infants' total grasps as they grew older (bar toy P<.001, candy toy P=.021). Conclusions: We observed significant changes in hand use and grasp sensor outcome measures with age that are consistent with maturation of grasp skills. We envision the evolution of hand use and grasp sensor technology into an inexpensive and convenient tool to track infant grasp development for early detection of possible developmental delay and/or cerebral palsy as a supplement to clinical evaluations.

2.
Curr Probl Pediatr Adolesc Health Care ; 47(7): 156-160, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28716514

ABSTRACT

Toe walking refers to the lack of heel strike during the stance phase of the gait cycle. It is a common variation of normal gait development in children. Persistent toe walking past 2-3 years of age warrants further evaluation as toe walking can be associated with cerebral palsy, muscular dystrophy, and autism spectrum disorders. The diagnosis of idiopathic toe walking is a diagnosis of exclusion used for children with persistent toe walking and no associated medical condition. Despite variable pathophysiology, the treatment of toe walking has similarities across diagnoses as it is focused on the maintenance of range of motion through the ankle.


Subject(s)
Gait Disorders, Neurologic/etiology , Toes , Ankle Joint/physiopathology , Autistic Disorder/complications , Autistic Disorder/diagnosis , Cerebral Palsy/complications , Cerebral Palsy/diagnosis , Child, Preschool , Gait/physiology , Gait Disorders, Neurologic/physiopathology , Gait Disorders, Neurologic/therapy , Humans , Male , Muscular Dystrophies/complications , Muscular Dystrophies/diagnosis , Range of Motion, Articular
3.
Curr Probl Pediatr Adolesc Health Care ; 47(7): 145-150, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28716515

ABSTRACT

Dysautonomia is a potentially life-threatening syndrome seen in many different types of brain injuries. It involves paroxysmal sympathetic hyperactivity and typically includes a constellation of symptoms, including: tachycardia, tachypnea, hyperthermia, hypertension, diaphoresis, hypertonia, and/or decerebrate or decorticate posturing. It is a clinical diagnosis of exclusion. A multimodal treatment approach is necessary including environmental modifications along with pharmacotherapy. Early management can help prevent comorbidities including secondary brain injury while also improving patient outcomes. This discussion serves as an overview of dysautonomia with a focus on management in the pediatric population including an example of a clinical algorithm and a review of the commonly used medications.


Subject(s)
Primary Dysautonomias/diagnosis , Primary Dysautonomias/therapy , Brain Injuries/complications , Humans , Primary Dysautonomias/etiology , Primary Dysautonomias/physiopathology , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...